focus -WSS

focus

author：Wikipedia 2025-09-10 00:59:30 - browse：932

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Ripples from Flovent's discontinuation is killing children with asthma

Wikipedia

explore

WSS

Oak Street deal isn't the answer to health care's woes

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Abbott's new stent may help patients with peripheral artery disease

WuXi Biologics execs register to lobby as Congress comes for the company

What a koala virus tells us about the human genome

Novo Nordisk testing Wegovy against alcohol

knowledge

focus

focus

Medical leaders decry Supreme Court decision on affirmative action

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Tori Bowie and the unacceptable rates of Black maternal death

WuXi Biologics beefs up its lobbying operation

The cancer drug shortage isn’t new — and neither are the solutions

STAT reporters are Pulitzer Prize finalists for investigative reporting

Jerome Adams on the need for new antivirals for Covid

Judge agrees to delay next hearing in Trump classified documents case

How to save PrEP access — and even expand it

Medicare wants to send $9 billion to 340B hospitals

explore

Free medical tuition alone isn't enough to close gaps in primary care

Ripples from Flovent's discontinuation is killing children with asthma

Medicare wants to send $9 billion to 340B hospitals

Novo Nordisk testing Wegovy against alcohol

Recent heat wave in the Mediterranean caused by climate change: Study

HHS suspends federal funding for EcoHealth Alliance

Wikipedia

explore

hotspot

leisure time